973 related articles for article (PubMed ID: 22390866)
1. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I
Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866
[TBL] [Abstract][Full Text] [Related]
2. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
Poomthavorn P; Suphasit R; Mahachoklertwattana P
Gynecol Endocrinol; 2011 Aug; 27(8):524-8. PubMed ID: 21501002
[TBL] [Abstract][Full Text] [Related]
3. [Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].
Chen SK; Fan X; Tang Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):374-6. PubMed ID: 19470261
[TBL] [Abstract][Full Text] [Related]
4. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
Pasquino AM; Pucarelli I; Accardo F; Demiraj V; Segni M; Di Nardo R
J Clin Endocrinol Metab; 2008 Jan; 93(1):190-5. PubMed ID: 17940112
[TBL] [Abstract][Full Text] [Related]
5. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
Paterson WF; McNeill E; Young D; Donaldson MD
Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
[TBL] [Abstract][Full Text] [Related]
6. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
[TBL] [Abstract][Full Text] [Related]
7. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
Léger J; Reynaud R; Czernichow P
J Pediatr; 2000 Dec; 137(6):819-25. PubMed ID: 11113839
[TBL] [Abstract][Full Text] [Related]
8. Time to menarche and final height after histrelin implant treatment for central precocious puberty.
Gillis D; Karavani G; Hirsch HJ; Strich D
J Pediatr; 2013 Aug; 163(2):532-6. PubMed ID: 23485026
[TBL] [Abstract][Full Text] [Related]
9. Body mass index and body composition in adolescents treated with gonadotropin-releasing hormone analogue triptorelin depot for central precocious puberty: data at near final height.
Chiocca E; Dati E; Baroncelli GI; Mora S; Parrini D; Erba P; Bertelloni S
Neuroendocrinology; 2009; 89(4):441-7. PubMed ID: 19176945
[TBL] [Abstract][Full Text] [Related]
10. Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height.
Lazar L; Kauli R; Pertzelan A; Phillip M
J Clin Endocrinol Metab; 2002 May; 87(5):2090-4. PubMed ID: 11994346
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function.
Heger S; Partsch CJ; Sippell WG
J Clin Endocrinol Metab; 1999 Dec; 84(12):4583-90. PubMed ID: 10599723
[TBL] [Abstract][Full Text] [Related]
12. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.
Bertelloni S; Baroncelli GI; Sorrentino MC; Perri G; Saggese G
Eur J Pediatr; 1998 May; 157(5):363-7. PubMed ID: 9625331
[TBL] [Abstract][Full Text] [Related]
13. [Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study].
Yuan JN; Liang L; Cai XD; Li Z; Bai M; Gu CP
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):896-9. PubMed ID: 22099200
[TBL] [Abstract][Full Text] [Related]
14. Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation.
Antoniazzi F; Zamboni G; Bertoldo F; Lauriola S; Mengarda F; Pietrobelli A; Tatò L
J Clin Endocrinol Metab; 2003 Mar; 88(3):1096-101. PubMed ID: 12629090
[TBL] [Abstract][Full Text] [Related]
15. Consensus statement on the use of gonadotropin-releasing hormone analogs in children.
Carel JC; Eugster EA; Rogol A; Ghizzoni L; Palmert MR; ; Antoniazzi F; Berenbaum S; Bourguignon JP; Chrousos GP; Coste J; Deal S; de Vries L; Foster C; Heger S; Holland J; Jahnukainen K; Juul A; Kaplowitz P; Lahlou N; Lee MM; Lee P; Merke DP; Neely EK; Oostdijk W; Phillip M; Rosenfield RL; Shulman D; Styne D; Tauber M; Wit JM
Pediatrics; 2009 Apr; 123(4):e752-62. PubMed ID: 19332438
[TBL] [Abstract][Full Text] [Related]
16. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
[TBL] [Abstract][Full Text] [Related]
17. Does GnRH analog improve the final height in Thai girls with idiopathic central precocious puberty?
Wacharasindhu S; Srivuthana S; Aroonparkmongkol S; Trinavarat P
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S51-6. PubMed ID: 11529380
[TBL] [Abstract][Full Text] [Related]
18. Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty.
van Gool SA; Kamp GA; Visser-van Balen H; Mul D; Waelkens JJ; Jansen M; Verhoeven-Wind L; Delemarre-van de Waal HA; de Muinck Keizer-Schrama SM; Leusink G; Roos JC; Wit JM
J Clin Endocrinol Metab; 2007 Apr; 92(4):1402-8. PubMed ID: 17284626
[TBL] [Abstract][Full Text] [Related]
19. Quantitative calcaneal ultrasound parameters and bone mineral density at final height in girls treated with depot gonadotrophin-releasing hormone agonist for central precocious puberty or idiopathic short stature.
Kapteijns-van Kordelaar S; Noordam K; Otten B; van den Bergh J
Eur J Pediatr; 2003 Nov; 162(11):776-80. PubMed ID: 13680381
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors for the effect of gonadotrophin releasing hormone analogue therapy on the height of girls with idiopathic central precocious puberty.
Brauner R; Malandry F; Rappaport R
Eur J Pediatr; 1992 Oct; 151(10):728-30. PubMed ID: 1425790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
